IMCD further strengthens its pharmaceutical offering in the Americas with the acquisition of Sachs Chemical, Inc.
August 01 2023 - 12:00AM
IMCD further strengthens its pharmaceutical offering in the
Americas with the acquisition of Sachs Chemical, Inc.
ROTTERDAM, The Netherlands (1 August 2023) – IMCD N.V.
(“IMCD” or “Company”), a global leading distribution partner,
formulator of speciality chemicals and ingredients, and solutions
provider, today announces that it signed an agreement to acquire
100% of the shares of Sachs Chemical, Inc. (“Sachs”).
“Sachs’ strong industry reputation, close customer relationships
and customized solutions for the pharmaceuticals industry are an
excellent fit with IMCD,” said Fernando J. Espinosa, Jr., LATAM
North Managing Director, IMCD. “Puerto Rico is an important
production location for the major US-based pharmaceuticals
customers, and this acquisition is an important step to accelerate
IMCD’s growth in the region.”
Sachs has operated in Puerto Rico since 1986. In 2015, the
business expanded to Costa Rica, supplying to the advanced
materials markets. Headquartered in the San Juan metropolitan area
of Puerto Rico, Sachs generated a revenue of approximately USD $50
million in 2022. It is ISO 9001:2015 certified, has strategically
located warehouses in Puerto Rico; plus a newly constructed
state-of-the-art warehouse and facility in San Jose, Costa Rica to
serve the Central American markets. IMCD welcomes Sachs’ 38
employees to its local organization.
“Sachs Chemical has been a beacon of innovation and customer
service in the region for nearly four decades,” said Michelle
Ortega, Operations Manager, Sachs Chemical. “The opportunity to
become part of IMCD’s worldwide presence is a catalyst for further
growth. With our shared corporate values and customer first
mentality, we look forward to providing our customers in the region
with a comprehensive approach to meet their needs.”
IMCD entered the Puerto Rican pharmaceuticals market in 2016.
The acquisition of Sachs marks the entity’s first purchase since
IMCD Puerto Rico was established. It demonstrates a firm intention
of business development in the pharmaceuticals industry in the
LATAM region.
The closing of the transaction is subject to customary closing
conditions and is expected to take place in August 2023.
Attached, the full press release in pdf format, the main visual
and the photo caption.
- main visual_IMCD further strengthens its pharmaceutical
offering in the Americas with the acquisition of Sachs Chemical,
Inc.
- Photo caption_IMCD further strengthens its pharmaceutical
offering in the Americas with the acquisition of Sachs
Chemical
- Press release_IMCD further strengthens its pharmaceutical
offering in the Americas with the acquisition of Sachs
Chemical
IMCD NV (EU:IMCD)
Historical Stock Chart
From Nov 2024 to Dec 2024
IMCD NV (EU:IMCD)
Historical Stock Chart
From Dec 2023 to Dec 2024
